These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32887784)

  • 1. Lesion evolution and neurodegeneration in RVCL-S: A monogenic microvasculopathy.
    Ford AL; Chin VW; Fellah S; Binkley MM; Bodin AM; Balasetti V; Taiwo Y; Kang P; Lin D; Jen JC; Grand MG; Bogacki M; Liszewski MK; Hourcade D; Chen Y; Hassenstab J; Lee JM; An H; Miner JJ; Atkinson JP
    Neurology; 2020 Oct; 95(14):e1918-e1931. PubMed ID: 32887784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrovascular reactivity in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations.
    Hoogeveen ES; Pelzer N; Ghariq E; van Osch MJ; Dahan A; Terwindt GM; Kruit MC
    J Cereb Blood Flow Metab; 2021 Apr; 41(4):831-840. PubMed ID: 33736510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREX1 is expressed by microglia in normal human brain and increases in regions affected by ischemia.
    Kothari PH; Kolar GR; Jen JC; Hajj-Ali R; Bertram P; Schmidt RE; Atkinson JP
    Brain Pathol; 2018 Nov; 28(6):806-821. PubMed ID: 30062819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial magnetic resonance imaging changes of pseudotumor lesions in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a case report.
    Yan Y; Jiang S; Wang R; Wang X; Li P; Wu B
    BMC Neurol; 2021 Jun; 21(1):219. PubMed ID: 34107918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Mortality and Vascular Phenotype in a Knock-In Mouse Model of Retinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations.
    Mulder IA; Rubio-Beltran E; Ibrahimi K; Dzyubachyk O; Khmelinskii A; Hoehn M; Terwindt GM; Wermer MJH; MaassenVanDenBrink A; van den Maagdenberg AMJM
    Stroke; 2020 Jan; 51(1):300-307. PubMed ID: 31805844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Imaging Characteristics of Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations.
    Hedderich DM; Lummel N; Deschauer M; Kümpfel T; Schuh E; Patzig M; Zimmer C; Huber T
    Clin Neuroradiol; 2020 Jun; 30(2):229-236. PubMed ID: 30627749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical associations of T2-weighted lesion load and lesion location in small vessel disease: Insights from a large prospective cohort study.
    Altermatt A; Gaetano L; Magon S; Bauer L; Feurer R; Gnahn H; Hartmann J; Seifert CL; Poppert H; Wuerfel J; Radue EW; Kappos L; Sprenger T
    Neuroimage; 2019 Apr; 189():727-733. PubMed ID: 30685330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shades of white: diffusion properties of T1- and FLAIR-defined white matter signal abnormalities differ in stages from cognitively normal to dementia.
    Riphagen JM; Gronenschild EHBM; Salat DH; Freeze WM; Ivanov D; Clerx L; Verhey FRJ; Aalten P; Jacobs HIL
    Neurobiol Aging; 2018 Aug; 68():48-58. PubMed ID: 29704648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal Vasculopathy With Cerebral Leukodystrophy: Clinicopathologic Features of an Autopsied Patient With a Heterozygous TREX 1 Mutation.
    Saito R; Nozaki H; Kato T; Toyoshima Y; Tanaka H; Tsubata Y; Morioka T; Horikawa Y; Oyanagi K; Morita T; Onodera O; Kakita A
    J Neuropathol Exp Neurol; 2019 Feb; 78(2):181-186. PubMed ID: 30561700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal neurodegeneration and brain MRI markers: the Rotterdam Study.
    Mutlu U; Bonnemaijer PWM; Ikram MA; Colijn JM; Cremers LGM; Buitendijk GHS; Vingerling JR; Niessen WJ; Vernooij MW; Klaver CCW; Ikram MK
    Neurobiol Aging; 2017 Dec; 60():183-191. PubMed ID: 28974335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of cognitive impairment with gray matter atrophy and cortical lesion load in clinically isolated syndrome.
    Diker S; Has AC; Kurne A; Göçmen R; Oğuz KK; Karabudak R
    Mult Scler Relat Disord; 2016 Nov; 10():14-21. PubMed ID: 27919482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter lesions and brain atrophy in systemic lupus erythematosus patients: correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus.
    Cannerfelt B; Nystedt J; Jönsen A; Lätt J; van Westen D; Lilja A; Bengtsson A; Nilsson P; Mårtensson J; Sundgren PC
    Lupus; 2018 Jun; 27(7):1140-1149. PubMed ID: 29523054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of brain lesion location for cognition in vascular mild cognitive impairment.
    Giorgio A; Di Donato I; De Leucio A; Zhang J; Salvadori E; Poggesi A; Diciotti S; Cosottini M; Ciulli S; Inzitari D; Pantoni L; Mascalchi M; Federico A; Dotti MT; De Stefano N;
    Neuroimage Clin; 2019; 22():101789. PubMed ID: 30927600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy.
    DiFrancesco JC; Novara F; Zuffardi O; Forlino A; Gioia R; Cossu F; Bolognesi M; Andreoni S; Saracchi E; Frigeni B; Stellato T; Tolnay M; Winkler DT; Remida P; Isimbaldi G; Ferrarese C
    Neurol Sci; 2015 Feb; 36(2):323-30. PubMed ID: 25213617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal neuroimaging relationships in progressive supranuclear palsy.
    Sintini I; Schwarz CG; Senjem ML; Reid RI; Botha H; Ali F; Ahlskog JE; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Parkinsonism Relat Disord; 2019 Sep; 66():56-61. PubMed ID: 31279635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathology and genetics of cerebroretinal vasculopathies.
    Kolar GR; Kothari PH; Khanlou N; Jen JC; Schmidt RE; Vinters HV
    Brain Pathol; 2014 Sep; 24(5):510-8. PubMed ID: 25323666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognition and gray and white matter characteristics of presymptomatic
    Papma JM; Jiskoot LC; Panman JL; Dopper EG; den Heijer T; Donker Kaat L; Pijnenburg YAL; Meeter LH; van Minkelen R; Rombouts SARB; van Swieten JC
    Neurology; 2017 Sep; 89(12):1256-1264. PubMed ID: 28855404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelin loss in white matter hyperintensities and normal-appearing white matter of cognitively impaired patients: a quantitative synthetic magnetic resonance imaging study.
    Park M; Moon Y; Han SH; Kim HK; Moon WJ
    Eur Radiol; 2019 Sep; 29(9):4914-4921. PubMed ID: 30488109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration.
    Kantarci K; Schwarz CG; Reid RI; Przybelski SA; Lesnick TG; Zuk SM; Senjem ML; Gunter JL; Lowe V; Machulda MM; Knopman DS; Petersen RC; Jack CR
    JAMA Neurol; 2014 Dec; 71(12):1547-54. PubMed ID: 25347157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.